Carl Knopke MD / IE Weight Loss

Carl Knopke MD / IE Weight Loss operates as a physician-supervised medical weight loss clinic serving patients throughout California via telehealth consultations. Dr. Carl Knopke, who holds board certifications in both Obesity Medicine and Family Medicine along with Fellowship status in the Obesity Medicine Association (FOMA) and the American Academy of Family Physicians (FAAFP), leads the practice with a clinical focus on evidence-based obesity treatment. Based in Riverside, the clinic addresses weight management as a chronic medical condition requiring specialized intervention rather than willpower alone, combining pharmacotherapy with behavioral modification strategies tailored to individual metabolic profiles.

The clinic's treatment protocols center on GLP-1 receptor agonist peptides, specifically Liraglutide and Semaglutide, which work by mimicking incretin hormones that regulate appetite and glucose metabolism. Dr. Knopke prescribes these medications as part of comprehensive weight management programs that include structured nutritional guidance and behavioral therapy components. Patients receive individualized dosing schedules based on their response to treatment, medical history, and weight loss goals. The practice evaluates candidates for peptide therapy through detailed metabolic assessments and monitors progress through regular telehealth check-ins, adjusting treatment parameters as patients move through different phases of weight reduction and maintenance.

Dr. Knopke's dual board certifications in Family Medicine and Obesity Medicine allow him to address weight management within the broader context of patients' overall health profiles, including comorbid conditions such as type 2 diabetes, hypertension, and metabolic syndrome. His FOMA fellowship designation indicates advanced training in the physiological, genetic, and environmental factors contributing to obesity, enabling him to design treatment approaches that account for the complex interplay between hormonal regulation, insulin resistance, and adipose tissue function. The clinic's model recognizes obesity as a disease requiring ongoing medical management rather than episodic dieting interventions.

Patients beginning treatment at IE Weight Loss complete an initial telehealth consultation where Dr. Knopke reviews medical history, current medications, previous weight loss attempts, and specific health goals. The clinic establishes baseline measurements and discusses realistic timelines for weight reduction based on clinical data. Follow-up appointments occur at intervals determined by the treatment protocol, typically every four to six weeks during active weight loss phases, with patients receiving guidance on managing potential side effects, adjusting caloric intake, and incorporating sustainable lifestyle modifications. The telehealth format allows California residents to access specialized obesity medicine care without geographic limitations, eliminating travel barriers that often interfere with consistent medical follow-up.

IE Weight Loss maintains a telehealth-exclusive practice model, providing access to board-certified obesity medicine expertise for patients across California who may lack local specialists in metabolic and weight management. The clinic coordinates with patients' primary care providers when appropriate and can serve as either primary obesity treatment or consultative support within a broader care team. Dr. Knopke's approach emphasizes patient education about the biological mechanisms underlying weight regulation, helping individuals understand how peptide therapies interact with their body's natural hunger and satiety signals. This educational component aims to shift patient perspective from viewing weight management as a character issue to understanding it as a medical condition responsive to appropriate pharmacological and behavioral interventions.